Cardiovascular disease is a major cause of morbidity and mortality in patients with type 2
diabetes mellitus, with a two-to fourfold increase in cardiovascular disease risk compared …

Cardiovascular disease (CVD) remains the leading cause of morbidity and mortality for
patients with type 2 diabetes, despite recent significant advances in management strategies …

The term “fat” may refer to lipids as well as the cells and tissue that store lipid (ie, adipocytes
and adipose tissue).“Lipid” is derived from “lipos,” which refers to animal fat or vegetable oil …

Obesity increases the risk of cardiovascular disease and premature death. Adipose tissue
releases a large number of bioactive mediators that influence not only body weight …

Insulin resistance is a key feature of the metabolic syndrome and often progresses to type 2
diabetes. Both insulin resistance and type 2 diabetes are characterized by dyslipidemia …

Abnormalities in lipid metabolism are very commonly observed in patients who are obese.
Approximately 60-70% of patients with obesity are dyslipidemic. The lipid abnormalities in …

Although LDL cholesterol (LDL‐C) is associated with an increased risk of coronary heart
disease, other lipoproteins and their constituents, apolipoproteins, may play an important …

Hypertriglyceridemia is a common lipid abnormality in persons with visceral obesity,
metabolic syndrome and type 2 diabetes. Hypertriglyceridemia typically occurs in …

The concurrence of visceral obesity, insulin resistance and dyslipidaemia comprises the
concept of the metabolic syndrome. The metabolic syndrome is an escalating problem in …

Postprandial hypertriglyceridemia is now established as an important risk factor for
cardiovascular disease (CVD). This metabolic abnormality is principally initiated by …